Reactance and Coping Responses to Tobacco Counter-Advertisements
Michelle S Wehbe1, Michael Basil1, Debra Basil1
1a Faculty of Management , University of Lethbridge , Lethbridge , Alberta , Canada.
Journal of Health Communication
|June 7, 2017
Summary
Tobacco counter-advertising affects smokers and nonsmokers differently. Messages attacking a smoker's specific brand may increase negative reactions, suggesting tailored interventions are needed for effective tobacco prevention.
Area of Science:
- Health Communication
- Psychology
- Tobacco Control
Background:
- Tobacco prevention messages often use educational, industry-attacking, or brand-attacking tactics.
- Reactance theory posits that attacks on self-identity, such as smoking a particular brand, can provoke negative responses.
- Smoker's self-identity can be closely linked to their smoking habits and chosen brands.
Purpose of the Study:
- To investigate differential reactions of smokers versus nonsmokers to tobacco counter-advertisements.
- To examine if attacking a smoker's preferred brand elicits greater reactance and maladaptive responses compared to other attacks.
- To inform the development of more effective tobacco prevention strategies.
Main Methods:
- A 2x2x2x2 experimental design.
- Utilized six distinct tobacco counter-advertisement messages.
- Involved 260 respondents to assess reactions and coping mechanisms.
Main Results:
- Smokers exhibited more maladaptive coping responses and fewer adaptive coping responses to tobacco counter-advertisements than nonsmokers.
- Reactions varied based on the degree of brand identification.
- Specific brand attacks led to heightened negative reactions among smokers.
Conclusions:
- Tobacco counter-advertising effectiveness differs significantly between smokers and nonsmokers.
- Interventions should tailor counter-advertising tactics based on smoker status and brand identification.
- Findings may inform public health campaigns beyond tobacco, addressing reactance in health-related messaging.
Related Concept Videos
Cognitive Dissonance
37.6K
Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
37.6K
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
1.7K
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
1.7K
Coping Strategies: Problem Focused
581
Coping strategies are methods people use to manage, tolerate, or reduce the effects of stressors. These strategies involve both behavioral and psychological actions to handle stressful situations. One common approach is problem-focused coping, which aims to change or eliminate the source of stress rather than merely addressing its consequences. This method involves taking direct action to resolve the issue causing stress.
For example, consider a student who struggles to understand their...
For example, consider a student who struggles to understand their...
581
Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.3K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.3K
Drugs Acting on Autonomic Ganglia: Stimulants
2.2K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.2K
Adrenergic Agonists: Therapeutic Uses
2.1K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.1K


